Letters show Nigeria OK'd Pfizer trial

Pfizer is back at the negotiating table with the Nigerian state of Kano in an attempt to finally settle claims about a meningitis drug trial the government contends was conducted illegally. The settlement talks are reconvening just as the state High Court ordered the feds to produce correspondence between the drugmaker and government officials about the Trovan study.

The letters could amount to Pfizer's smoking gun. According to a company statement, they show that the state and federal government approved the trial and authorized Pfizer doctors to treat patients as part of the study.

Last week, Pfizer offered $10 million to the alleged victims and said it would both upgrade the hospital where the drug trial took place and build a pediatrics ward in a public hospital, but the Kano government turned that offer down.

- see the story at All Africa
- check out the Forbes news

Related Articles:
Nigeria arrests Pfizer director
Pfizer-Nigeria lawsuit talks fall apart
Nigeria calls Pfizer execs to trial
Trial deaths spur criminal charges against Pfizer
Pfizer 'exploited' children in African trial

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Incyte and Novartis' Jakafi is eying a nod in chronic graft vs. host disease—and it may just have the data to get it done.

With a slate of vaccine authorizations on the horizon, vaccine execs from a trio of leading shot makers are looking at distribution hurdles ahead.

News of an FDA plant inspection for a Macrogenics drug boosted investor confidence in BMS' ability to meet its year-end deadline for liso-cel.